Cooper Companies (The) (COO) Earnings Date & Reports

Key Takeaways

• Second quarter 2026 revenue reached a record $1.082 billion, rising 8% year-over-year and 5% organically.
• Non-GAAP diluted EPS of $1.21 exceeded consensus estimates of $1.10, marking the tenth consecutive quarter of outperformance.
• CooperVision revenue grew 8% to $723.5 million; CooperSurgical revenue increased 8% to $358.0 million.
• GAAP EPS of $(0.40) reflected a $271.6 million pre-tax litigation charge tied to a prior product recall.
• Company raised fiscal 2026 revenue and non-GAAP EPS guidance ranges.
• Free cash flow totaled $96.4 million for the quarter.

Earnings Context and Why It Matters

The Cooper Companies operates in the medical device sector through its CooperVision contact lens and CooperSurgical women's health businesses. Fiscal second quarter results provide investors with an early read on demand trends in vision correction and fertility solutions amid evolving healthcare spending and competitive dynamics. Strong organic growth and consistent earnings beats underscore operational execution following last year's reorganization, while the litigation resolution clears a notable overhang and supports focus on long-term growth initiatives.

Reported Results

For the fiscal second quarter ended April 30, 2026, The Cooper Companies reported revenue of $1.082 billion, an 8% increase from the prior-year period and 5% organically. CooperVision contributed $723.5 million (up 8%), while CooperSurgical added $358.0 million (up 8%). Non-GAAP diluted earnings per share reached $1.21, up 26% year-over-year and ahead of analyst expectations. GAAP diluted EPS was $(0.40) after a $271.6 million litigation charge related to a December 2023 voluntary recall of embryo culture media. Gross margin held steady at 68% on both GAAP and non-GAAP bases. The company updated fiscal 2026 guidance to revenue of $4.285–$4.321 billion and non-GAAP diluted EPS of $4.58–$4.66.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. AI Screener

Market Reaction and Investor Sentiment

Shares of The Cooper Companies traded higher following the June 4 release, reflecting investor focus on the revenue record and non-GAAP earnings beat despite the one-time GAAP charge. Analysts highlighted the tenth straight quarter of outperformance and raised guidance as positive signals. Sentiment remains constructive on the company’s ability to deliver consistent growth while resolving legacy issues.

Forward Outlook and Key Factors to Monitor

With updated fiscal 2026 guidance in place, investors will watch for sustained organic revenue momentum in both CooperVision and CooperSurgical segments. Key areas include new product adoption in toric and multifocal lenses, demand trends in fertility solutions, and the impact of tariffs or currency fluctuations on margins.

Operational discipline remains a focus, with benefits expected from prior reorganization efforts. Free cash flow generation will be monitored closely as the company targets cumulative free cash flow exceeding $2.2 billion over fiscal years 2026–2028.

Broader industry dynamics such as healthcare utilization rates and competitive pricing in contact lenses could influence results. Upcoming quarterly updates will provide further visibility into guidance achievement and any strategic developments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations